Home
Storia in 3 fonti
Semaglutide reduces weight, improves cardiometabolic parameters for older adults
Once-weekly injectable semaglutide 2.4 mg was linked to reductions in body weight and improvements in multiple cardiometabolic parameters for older adults with obesity, according to a pooled analysis of the STEP trials. “Older adults represent, in many countries, the age group with the higher prevalence of obesity and related complications,” Luca Busetto, PhD, professor in nutrition and dietetic
- ·
ansa.it
Il farmaco antiobesità semaglutide efficace anche per proteggere il cuore in menopausa - Diabete news - Ansa.it
Nuovi dati sull'efficacia della molecola anti-obesità semaglutide per la perdita di peso, la protezione cardiovascolare e l'emicrania nelle donne in menopausa sono stati…
- ·
healio.com
Semaglutide reduces weight, improves cardiometabolic parameters for older adults
Once-weekly injectable semaglutide 2.4 mg was linked to reductions in body weight and improvements in multiple cardiometabolic parameters for older adults with obesity, according…
- ·
infobae.com
El efecto de las inyecciones para bajar de peso en mujeres mayores de 40 años: una investigación reveló nuevos datos
Análisis presentados en el Congreso Europeo de Obesidad 2026 mostraron el impacto de la molécula semaglutida en distintas fases de la menopausia. Los resultados mostraron una…